US equity
·Updated Aug 26, 21:38 UTCAMGN
Amgen Inc.
Health Care·Mega cap·$238B
440.34
-0.4% today
No price history available for this name yet.
Returns & momentum
1D-0.4%
1W+0.1%
1M+12.7%
3M+31.8%
6M+16.1%
1Y+56.9%
YTD—
All-time—
Range & moving averages
Price440.34
52w high-1.5%
52w low+67.8%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume2.3M
Turnover$1.0B
Market cap$238B
RVOL0.86×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.8B | $33.4B | $28.2B | $26.3B | $26.0B | $25.4B | $23.4B | $23.7B | $22.8B | $23.0B | $21.7B | $20.1B | $17.3B | $15.6B | $15.1B | $14.6B |
| Cost of revenue | $12.0B | $12.9B | $8.5B | $6.4B | $6.5B | $6.2B | $4.4B | $4.1B | $4.1B | $4.2B | — | — | — | — | — | — |
| Selling, general & admin | $7.0B | $7.1B | $6.2B | $5.4B | $5.4B | $5.7B | $5.2B | $5.3B | $4.9B | $5.1B | $4.8B | $4.7B | $4.8B | $4.5B | $4.0B | $3.8B |
| Operating income | $9.1B | $7.3B | $7.9B | $9.6B | $7.6B | $9.1B | $9.7B | $10.3B | $10.0B | $9.8B | $8.5B | $6.2B | $5.6B | $4.3B | $5.5B | $5.5B |
| Income tax | $1.3B | $519M | $1.1B | $794M | $808M | $869M | $1.3B | $1.2B | $7.6B | $1.4B | $1.0B | $427M | $664M | $467M | $690M | $599M |
| Net income | — | — | — | — | — | $7.3B | $7.8B | $8.4B | $2.0B | $7.7B | $6.9B | $5.2B | $4.3B | $3.7B | $4.6B | $4.6B |
| EPS — basic | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 | $12.40 | $12.96 | $12.70 | $2.71 | $10.32 | $9.15 | $6.80 | $5.61 | $4.07 | $4.82 | $4.53 |
| EPS — diluted | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $12.88 | $12.62 | $2.69 | $10.24 | $9.06 | $6.70 | $5.52 | $4.04 | $4.79 | $4.51 |
| Shares — basic | 538M | 537M | 535M | 538M | 570M | 586M | 605M | 661M | 731M | 748M | 758M | 759M | 775M | 905M | 960M | 1.02B |
| Shares — diluted | 542M | 541M | 538M | 541M | 573M | 590M | 609M | 665M | 735M | 754M | 766M | 770M | 787M | 912M | 965M | 1.02B |
From SEC filings (public domain), since 2008. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.